Online Patient Attitudes Toward Cutaneous Immune-Related Adverse Events Attributed to Nivolumab and Pembrolizumab: Sentiment Analysis.

JMIR Dermatol · 2024 · PMC11099803 · PMID 38696235

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

did not reach statistical significanceP =.07so close (0.05 < p ≤ 0.1)

A trend toward higher sentiment scores was exhibited in DS-containing reviews, though it did not reach statistical significance ( P =.07).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.